Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 1753673, 7 pages
https://doi.org/10.1155/2017/1753673

Research Article

Medicinal Plants from Northeastern Brazil against Alzheimer’s Disease

Alexandre Batista Penido,¹ Selene Maia De Morais,² Alan Bezerra Ribeiro,³ Daniela Ribeiro Alves,⁴ Ana Livya Moreira Rodrigues,⁵ Leonardo Hunaldo dos Santos,⁶ and Jane Eire Silva Alencar de Menezes⁷

¹Centro de Ciências Sociais Saúde e Tecnologia, Curso de Enfermagem, Universidade Federal do Maranhão, Rua Urbano Santos, s/n, Centro, 65900-410 Imperatriz, MA, Brazil
²Departamento de Química, Laboratório de Química e Produtos Naturais, Universidade Estadual do Ceará, Campus do Itaperi, Av. Dr. Silas Munguba 1.700, 60.714-903 Fortaleza, CE, Brazil
³Centro de Ciências Sociais Saúde e Tecnologia, Curso de Engenharia de Alimentos, Universidade Federal do Maranhão, Rua Urbano Santos, s/n, Centro, 65900-410 Imperatriz, MA, Brazil
⁴Núcleo de Pesquisa em Sanidade Animal, Universidade Estadual do Ceará, Campus do Itaperi, Av. Dr. Silas Munguba 1.700, 60.714-903 Fortaleza, CE, Brazil
⁵Laboratório de Química e Produtos Naturais, Universidade Estadual do Ceará, Campus do Itaperi, Av. Dr. Silas Munguba 1.700, 60.714-903 Fortaleza, CE, Brazil
⁶Centro de Ciências Sociais Saúde e Tecnologia, Curso de Licenciatura em Ciências Naturais/Biologia, Universidade Federal do Maranhão, Rua Urbano Santos, s/n, Centro, 65900-410 Imperatriz, MA, Brazil
⁷Centro de Ciências e Tecnologia, Universidade Estadual do Ceará, Campus do Itaperi, Av. Dr. Silas Munguba 1.700, 60.714-903 Fortaleza, CE, Brazil

Correspondence should be addressed to Alexandre Batista Penido; penidoufma@gmail.com

Received 10 January 2017; Accepted 2 February 2017; Published 21 February 2017

Academic Editor: Ayodele J. Akinyemi

Copyright © 2017 Alexandre Batista Penido et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Alzheimer’s disease (AD) has been linked with oxidative stress, acetylcholine deficiency in the brain, and inflammatory processes. In the northeast region of Brazil, various plants are used to treat several diseases associated with these processes; then an antioxidant test was performed with those plants in a previous work and twelve species with higher antioxidant activity were selected for AChE inhibition evaluation. The phenolic compounds content was determined by Folin–Ciocalteu test and flavonoid content with AlCl₃ reagent using UV-visible spectrophotometry. The antioxidant activity was assessed analyzing the inhibitory activity against 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2-azinobis-3-ethylbenzothiazoline-6-sulfonate (ABTS) and by the β-carotene/linoleic acid system and acetylcholinesterase inhibition using qualitative and quantitative tests. The combination of better acetylcholinesterase inhibitory and antioxidant activities pointed out six species, in descending order, as the best potential sources of therapeutic agents against AD: Hancornia speciosa > Myracrodruon urundeuva > Copaifera langsdorffii > Stryphnodendron coriaceum > Psidium guajava > Mangifera indica. Besides, the phenolic compounds in the species probably contribute to these activities. However, further pharmacological studies to assess the specific applications of these plants against AD are required to confirm these results.

1. Introduction

AD was first described in 1906 by the German physician Alois Alzheimer. It is the most common form of dementia and affects 24 millions of people worldwide. During the progression of AD, the destruction of brain cells leads to gradual memory loss, deterioration of intellectual function, loss of speech, disorientation, and difficulty walking. Factors involved in AD include acetylcholine deficiency, free radicals, and brain tissue inflammation. There is currently no cure for AD, but several drugs aimed at delaying its progression are available, and new and more effective drugs are being investigated [1].

A promise approach in the treatment of Alzheimer’s disease (AD) is the use of natural products, which increase acetylcholine levels necessary for memory function [2]. Acetylcholine is a neurotransmitter that is essential for healthy memory, and mental health problems that involve memory loss are directly or indirectly related to acetylcholine. Low levels of this neurotransmitter have been shown to have an important role in the pathogenesis of AD [3]. As a result, many studies aimed at finding treatments for memory changes, such as those that occur in AD, are focused on acetylcholine. AChEIs inhibit acetylcholinesterase, the enzyme responsible for the breakdown of acetylcholine. Studies on plants with acetylcholinesterase inhibitory activity are currently underway, with the aim of discovering new active compounds that are less costly and have fewer adverse side effects than synthetic drugs [4].

Free radicals also a play a role in many common diseases, including AD. Therefore, plant extracts with antioxidant activity also have potential therapeutic value. For example, lipid peroxidation is a reaction mediated by free radicals, in which fatty acid breakdown occurs in cell membranes, thereby reducing membrane fluidity. This process, in association with other events, can lead to pathological conditions such as heart disease, some types of cancer, brain ischemia, and inflammatory conditions [5]. Natural antioxidants obtained from foods, such as phenolic compounds and carotenoids, inhibit lipid peroxidation via their free-radical scavenging activity. The intake of fruits that are rich in phenolic compounds also reduces the risk of developing various types of cancer [6, 7].

A significant reduction in the incidence of chronic and degenerative diseases has been observed in populations with diets comprising mainly natural foods that contain phenolic compounds with antioxidant activity, such as fruits and cereal. The most common antioxidants present in the foods in our diet are vitamin C, vitamin E, selenium, and carotenoids, and in addition phenolic compounds such as phenolic acids and flavonoids also contribute to antioxidant activity [8].

Plants that have positive effects on cognitive disorders, as well as strong acetylcholinesterase inhibitory, anti-inflammatory, and antioxidant activities, are of potential clinical interest for the treatment of AD ([9, 10]).

In this study, an ethnobotanical survey of the main plants used in the northeast region of Brazil was conducted to select medicinal plants that are potential sources of therapeutic agents against AD [11]. Sixty species were found and tested for antioxidant activity. Subsequently, the 34 species that exhibited the highest antioxidant activity were selected, and their phenol and flavonoid content was determined. The plants that yielded the best results were then subjected to acetylcholinesterase inhibition tests. The present study assessed the relationships between these properties in the plants, with the aim of discovering new phytotherapics that can be used in the treatment of AD.

2. Materials and Methods

2.1. Collection and Preparation of Plant Extracts

The ethnobotanical and ethnopharmacological study was approved on October 1, 2014 (approval number: 814.666) and was conducted between October 2014 and March 2015. The aim of the study was to investigate some of the main plant species used for medicinal purposes in the northeast region of Brazil, especially with regard to memory. The species were identified morphologically by Professor Ana Zélia Silva, Department of Pharmacy of the Federal University of Maranhão, and were deposited in the Atticus Seabra Herbarium (Table 1). The plant samples were dried, ground in cutting mills, macerated with 70% ethanol for 7 days, filtered, evaporated in a rotary evaporator under reduced pressure, frozen, and freeze-dried. All of the plant names are listed at http://www.theplantlist.org.

Table 1: Selected medicinal plants from Northeastern Brazil with high antioxidant activity.

Species family 
Local name
Voucher
number
Part used
Traditional use
Biological and pharmacological activities

Anadenanthera peregrina (L.) Speg. Fabaceae 
Angico
1423
Bark
Expectorant, flu, bronchitis, asthma, cough
Anti-inflammatory [16]

Bauhinia forficata Link
Fabaceae 
Mororó
1322
Bark
Diabetes, kidney problems
Hypoglycemic, antioxidant, anti-inflammatory, diuretic [17–19]

Copaifera langsdorffii Desf. Fabaceae 
Copaiba
1400
Bark
Inflammation, wound healing
Anti-inflammatory, antioxidant, healing, antimalarial, leishmanicidal [20–23].

Euterpe oleracea Mart
Arecaceae 
Açaí
1425
Seed
Memory, high blood pressure, general illness
Antioxidant, anti-inflammatory, antinociceptive, antihypertensive [24–26]

Hancornia speciosa Gomes Apocynaceae 
Mangaba 
1399
Bark
Wound healing, inflammation, stomach ulcers, stomach pain
Antihypertensive, antioxidant, anti-inflammatory [27, 28]

Luehea divaricata Mart. & Zucc Malvaceae 
Açoita cavalo
1117
Leaf
Inflammation, diabetes, irregular menstruation
Anti-inflammatory, antinociceptive, immunostimulatory [29]

Mangifera indica L. Anacardiaceae 
Manga
1213
Leaf
Headache, ulcers, fever
Antiulcerogenic, antioxidant, anti-inflammatory [30]

Myracrodruon urundeuva Allemão Anacardiaceae 
Aroeira-Sertão
1420
Bark
Inflammation, vaginal infection, sore throat, wound healing
Anti-inflammatory, healing [31]

Plathymenia reticulata Benth FabaceaeCandeia
1414
Bark
Inflammation, liver problems, bleeding
Anti-inflammatory, antihemorrhagic, antibiotic, antioxidant, antivenom [26, 32]

Psidium guajava L.
Myrtaceae 
Goiaba
1182
Leaf
Diarrhea
Antidiarrheal, antioxidant [33, 34]

Stryphnodendron coriaceum Beth
Fabaceae 
Barbatimão
1033
Leaf
Vaginal infection, toothache, wound healing, inflammation
Anti-inflammatory, antimicrobial, healing, antiulcerogenic, antileishmanial, antioxidant [35, 36]

Syzygium aromaticum (L.)
Merr. & L. M. Perry Myrtaceae 
Cravo da India
1428
Fruit
Menstrual colic, pain, sedative, inflammation
Antioxidant, antidiabetic, analgesic, anti-inflammatory [37, 38]

2.2. Phytochemical Analysis

2.2.1. Determination of Total Phenol Content

Total phenol content was determined using the Folin–Ciocalteu method, with some modifications [12]. The sample was dissolved in methanol, and Folin–Ciocalteu reagent, distilled water, and 15% sodium carbonate were added. After incubation in the dark for 2 hours, the absorbance was measured at 750 nm using a UV/VIS spectrophotometer. The results are expressed as the gallic acid equivalent per gram of extract (mg GAE/g) based on a linear equation for a standard curve prepared with gallic acid (0.1–0.5 mg/mL).

2.2.2. Determination of Flavonoid Content

The flavonoid content was determined using the method described by Funari and Ferro [13]. A volume of 2 mL of the extract solution (2 mg/mL) was used, to which 1 mL of 2.5% AlCl₃ solution was added. After incubation in the dark for 30 minutes, the absorbance was measured at 425 nm. A yellow color indicated the presence of flavonoids. The flavonoid content was calculated and expressed in mg of quercetin equivalent per gram of extract (mg EQ/g), based on a standard curve prepared with quercetin.

2.2.3. Assessment of Antioxidant Activity via DPPH Radical Reduction

Antioxidant activity was assessed using a previously described method [14], with some modifications. Dilution series of the samples and control, in methanol, were prepared, to obtain the following concentrations: 3.125, 6.25, 12.5, 25.0, 50.0, and 100 μg/mL. Then, 2 mL of DPPH (0.004%) was added. Methanol was used as a negative control. After a period of 30 minutes in the dark, the absorbance was measured at 517 nm using a UV-VIS spectrophotometer. The percentage inhibition was calculated according to the equation: IP% = [(absorbance of DPPH − absorbance of the extract)/absorbance of DPPH] × 100. The IC₅₀ values were determined by linear regression of the plotted data.

2.2.4. Assessment of Antioxidant Activity by the ABTS Method

Antioxidant activity was assessed using the ABTS method, as described by Re et al. [15]. The ABTS solution (7 mM, 5 mL) was mixed with 88 μL of potassium persulfate (140 mM), agitated, and kept in the dark at room temperature for 16 hours. Then, 1 mL of this solution was added to 99 mL of ethanol, and the absorbance was measured at 734 nm. A series of solutions of the plant extracts with decreasing concentrations was prepared, and 3.0 mL of ABTS solution was added to 30 μL of these solutions after 6 minutes. The absorbance was then measured at 734 nm. The IC₅₀ values were calculated by linear regression.

2.2.5. Assessment of Antioxidant Activity by the β-Carotene/Linoleic Acid Method

The β-carotene/linoleic acid method was used according to Wettasinghe and Shahidi [39] in which 1 mg of β-carotene was diluted in 5 mL of chloroform. Aerated water, 200 μL of Tween 40, 20 μL of linoleic acid, and 2 mL of β-carotene were used to prepare the β-carotene solution. The spectrophotometer was adjusted to a wavelength of 470 nm. For the stock solution, 12.5 mg of sample was dissolved in 25 mL of methanol. After the final concentrations were obtained, the β-carotene solution (different concentrations) and the blank were placed in cuvettes. The absorbance was measured; then the solutions were placed in a water bath for 2 hours, and the absorbance was measured again. The calculation was performed using the following formula: IC% = 1 − [(absorbance of the sample − absorbance of the sample after 2 hours)/(absorbance of the blank − absorbance of the blank after 2 hours)] × 100. The IC₅₀ values were calculated by linear regression.

2.2.6. Determination of Acetylcholinesterase Inhibitory Activity

The acetylcholinesterase inhibitory activity was qualitatively assessed using the method by Ellman et al. [40] adapted for thin layer chromatography [41] and was quantitatively measured using an Elisa BIOTEK microplate reader (model ELX 800 with Gen5 V2.04.11 software), based on the method by Ellman et al. [40] modified by Trevisan et al. [42].

2.2.7. Statistical Analysis

All of the experiments were performed in triplicate, and the results were expressed as the mean ± standard deviation. The differences between the values were examined using analysis of variance (ANOVA), and the results were compared using the Tukey test at a 95% confidence level. GraphPad Prism software version 5.01 was used.

3. Results and Discussion

The present study began with an ethnobotanical investigation of 60 species, to identify active agents that may be used in the treatment of several diseases, including AD [11]. AD is one of the most prevalent neurodegenerative diseases in humans, and its cause is multifactorial, but free radicals and acetylcholinesterase are known to be strongly associated with this disease. Therefore, the aim of this study was to analyze the main medicinal plants used in the northeast region of Brazil and determine their antioxidant activities, phenolic compound content, and flavonoid content, and acetylcholinesterase inhibitory activity.

Phenolic compounds, flavonoids, and tannins are the major antioxidant agents and free-radical scavengers in plants. Several methods can be used to assess the antioxidant activity of a sample; however, one method alone cannot provide precise enough data to determine a plant’s free-radical scavenging or prevention capacity or the consequent amount of lipid oxidation, especially in plant extracts that are composed of several chemical compounds that act via different mechanisms [43]. As a result, in this study, the species were tested using the DPPH, ABTS, and β-carotene/linoleic acid methods.

Table 1 identifies the main species assessed in this study. Their scientific and common names are given, along with their voucher numbers, the parts of the plant typically used, and their traditional uses and biological and pharmacological reports.

Table 2 shows the results of antioxidant tests, phenols, and flavonoid content an AChE inhibition. In bold, six plant species were marked since they were chosen as being better candidates as anti-AChE agents. This choice took into account the combination of the two kinds of actions: H. speciosa, C. langsdorffii, M. urundeuva, M. indica, P. guajava, and S coriaceum.

Table 2: Antioxidant activity (DPPH, ABTS, and β-carotene/linoleic acid tests), phenolics content, flavonoid content, and acetylcholinesterase inhibitory activity of selected medicinal plant species used in the northeast region of Brazil.

Species
DPPH
μg/mL
β-Carotene
μg/mL
ABTS
μg/mL
Phenols
Mg GAE/g extract
Flavonoids
mg EQ/g extract
AChEI
IC₅₀ 
μg/mL

Ap
53.65 ± 0.24
12.51 ± 0.66
2.12 ± 0.01
62.23 ± 0.15
0.88 ± 0.04
397.23 ± 0.09

Bf
49.39 ± 0.47
13.72 ± 0.22
3.44 ± 0.01

4.62 0.03
10.90 ± 1.44

Cl
45.23 ± 0.17
13.74 ± 0.99
2.64 ± 0.02
48.03 ± 0.30
4.35 ± 0.01
14.86 ± 1.79

Eo
28.54 ± 0.78
22.09 ± 0.81
2.04 ± 0.17
51.10 ± 0.59
1.31 ± 0.06
130.29 ± 0.37

Hs
30.70 ± 0.68
5.73 ± 0.38
2.18 ± 0.06
60.26 ± 0.45
8.64 ± 0.02
10.13 ± 0.17

Ld
38.48 ± 0.53
10.77 ± 0.55
3.98 ± 0.11
55.81 ± 0.39
0.83 ± 0.04
111.54 ± 0.33

Mi
50.78 ± 0.47
1.18 ± 0.16
2.13 ± 0.05
28.79 ± 1.16
13.51 ± 0.04
29.67 ± 0.42

Mu
48.01 ± 0.35
6.92 ± 1.42
2.14 ± 0.02
61.28 ± 0.44
0.96 ± 0.03
10.75 ± 0.15

Pr
51.33 ± 0.34
19.67 ± 0.36
3.93 ± 0.21
61.56 ± 0.27
0.91 ± 0.01
46.93 ± 0.76

Pg
40.42 ± 0.81
15.06 ± 0.40
2.22 ± 0.06
37.85 ± 0.53
3.82 ± 0.02
18.98 ± 0.11

Sc
45.09 ± 0.15
13.71 ± 0.21
1.96 ± 0.05
52.85 ± 0.02
1.05 ± 0.01
17.56 ± 0.50

Sa
56.54 ± 0.99
8.81 ± 0.26
4.00 ± 0.07
91.27 ± 0.26
2.02 ± 0.01
152.25 ± 0.04

Ru
39.20 ± 0.16
9.25 ± 0.01
2.05 ± 0.08
—
—
—

Es
—
—
—
—
—
19.53 ± 0.08

The data are presented as the mean ± standard deviation and were analyzed using ANOVA followed by a Tukey test. Values with different superscript letters are significantly different (). Flavonoid content: mg EQ/g extract; phenolic compounds content: mg GAE/g extract; 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2-azinobis-3-ethylbenzothiazoline-6-sulfonate (ABTS), β-carotene/linoleic acid, and acetylcholinesterase inhibition (AChEI): IC₅₀ (μg/mL). Ap, Anadenanthera peregrina (bark); Bf, Bauhinia forficata (bark); Cl, Copaifera langsdorffii (bark); Eo, Euterpe oleracea (seeds), Hs, Hancornia speciosa (bark); Ld, Luehea divaricata (leaves); Mi, Mangifera indica (leaves); Mu, Myracrodruon urundeuva (bark); Pr, Plathymenia reticulata (leaves); Pg, Psidium guajava (leaves); Sc, Stryphnodendron coriaceum (bark); Sa, Syzygium aromaticum (fruits); Ru, rutin (antioxidant control); Es, eserine (acetylcholinesterase control); —: not performed.

The species that exhibited the best antioxidant activity in the three tests and anticholinesterase activity was H. speciosa. This plant is currently used in the treatment of several conditions, including fractures, inflammation, ulcers, pain, hypertension, and diabetes, and its effects are probably attributable to the antioxidant capacity of compounds present, such as phenols, tannins, flavones, flavonoids, leucoanthocyanidins, and alkaloids [44]. H. speciosa also exhibited the best results among all the species tested in terms of anticholinesterase activity. This activity, combined with its high content of phenols and flavonoids, means H. speciosa may be the best source among the assessed species for research into new therapeutic agents against several diseases, including AD.

B. forficata is currently used as a hypoglycemic in the treatment of diabetes. Recent studies have demonstrated that insulin metabolism is important in the AD signaling pathway, and there is evidence that alteration of insulin metabolism plays a role in the molecular pathogenesis of AD [45]. Patients with AD have lower levels of insulin, and when these levels are corrected, there is an improvement in cognitive processes [4], further supporting the idea that B. forficata has potential in the treatment of AD. This plant also had good anticholinesterase activity and a high antioxidant capacity and therefore could be another source of agents against AD. B. forficata also exhibits a high flavonoid content, which confirms that this species is a potential source of promising natural resources for studies on new AD treatment strategies [46].

C. langsdorffii and compounds isolated from it are reported as gastric mucosal protective agents that act by increasing the production of mucus [47]. Because this species exhibited high acetylcholinesterase inhibitory activity, this mechanism may contribute to the plant’s ability to increase acetylcholine, a neurotransmitter involved in several biological processes, including the production of mucus, healing, inflammation, and gastric ulcers.

M. indica exhibits the highest flavonoid content among the species tested, as well as high antioxidant activity, which probably contributes to its anti-inflammatory properties [30], and high anticholinesterase activity, as was demonstrated in the present study. These data confirm the results of other studies with this species, which have shown it to have anticholinesterase, anti-inflammatory, antioxidant, and antidiabetic activities. These pharmacological activities probably result from the phenolic compounds that have been isolated in this species, such as mangiferin, and suggest that M. indica is another promising source of agents for the treatment and prevention of AD [48]. Recent studies on cholinergic dysfunction, oxidative stress, and their relationship with memory have demonstrated that ethanol extracts of the fruits of M. indica improved memory function [49]. M. indica fruit extracts have potential neuroprotective activity and improve cognitive impairment, because they reduce oxidative stress and increase cholinergic function [49].

M. urundeuva bark tinctures are largely used as anti-inflammatory phytotherapics and the action is explained due to the levels of tannins and dimeric chalcones [50]. However, there are few studies on the effects of this species on the central nervous system. Extracts of M. urundeuva were used in animal models of Parkinson’s disease and were found to reverse behavioral changes and increase the number of neurons and their viability. At the neurochemical level, these extracts prevented the reduction of dopamine level, because dopamine levels are low in Parkinson’s disease, and probably promote neuroprotection via their antioxidant and anti-inflammatory activities, and these results demonstrate that this plant is useful in the treatment of neurodegenerative diseases [51]. M. urundeuva were shown to have excellent acetylcholinesterase inhibitory activity, a high phenol content, and high antioxidant activity which shows that M. urundeuva also has potential as a source of therapeutic agents against AD.

P. guajava also exhibited high antioxidant activity and had a high content of phenolic compounds and flavonoids, in accordance with a previous study, and it was found to be useful in alleviating various oxidative stress-related diseases [52]. The antidiarrheal activity of the plant is probably due to the high phenolic content.

S. coriaceum exhibits acetylcholinesterase inhibitory activity, as well as antioxidant, anti-inflammatory, antimicrobial, healing, antiulcerogenic, and leishmanicidal activities [35, 36]. The S. coriaceum extract was shown to have excellent acetylcholinesterase inhibitory and antioxidant activities, which make it another potential source of therapeutic agents against AD.

4. Conclusions

The assessed natural products are promising sources of pharmacological agents for the treatment of AD, which affects 24 million people worldwide. The strategy chosen seems to be a good choice by selecting plants, which are inhibitors of acetylcholinesterase, and also possesses antioxidant activity. Phenols and flavonoids are important natural products that inhibit acetylcholinesterase and thus restore acetylcholine level essential for brain function; therefore the six medicinal species selected are promising sources of natural products that can be used in studies for discovering new therapeutic compounds against AD.

Competing Interests

All authors declare that there is no financial/commercial conflict of interests.

Acknowledgments

This work was supported in part by Universidade Federal do Maranhão and Universidade Estadual do Ceará-Renorbio. Alexandre Batista Penido is grateful to the Fundação de Amparo a Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão (FAPEMA) that provided a scholarship. CNPq also gave financial support.

References

A. Singhal, O. Bangar, and V. Naithani, “Medicinal plants with a potential to treat Alzheimer and associated symptoms,” International journal of Nutrition, Pharmacology, Neurological Diseases, vol. 2, no. 2, pp. 84–91, 2012.

L. Huang, T. Su, and X. Li, “Natural products as sources of new lead compounds for the treatment of Alzheimer’s disease,” Current Topics in Medicinal Chemistry, vol. 13, no. 15, pp. 1864–1878, 2013.

T. O. Elufioye, E. M. Obuotor, A. T. Sennuga, J. M. Agbedahunsi, and S. A. Adesanya, “Acetylcholinesterase and butyrylcholinesterase inhibitory activity of some selected Nigerian medicinal plants,” Brazilian Journal of Pharmacognosy, vol. 20, no. 4, pp. 472–477, 2010.

A. De Falco, D. S. Cukierman, R. A. Hauser-Davis, and N. A. Rey, “Alzheimer's disease: etiological hypotheses and treatment perspectives,” Quimica Nova, vol. 39, no. 1, pp. 63–80, 2016.

G. G. Duthie, S. J. Duthie, and J. A. M. Kyle, “Plant polyphenols in cancer and heart disease: implications as nutritional antioxidants,” Nutrition Research Reviews, vol. 13, no. 1, pp. 79–106, 2000.

A. K. Tiwari, “Antioxidants: new-generation therapeutic base for treatment of polygenic disorders,” Current Science, vol. 86, no. 8, pp. 1092–1102, 2004.

Y. K. Park, E. Park, J.-S. Kim, and M.-H. Kang, “Daily grape juice consumption reduces oxidative DNA damage and plasma free radical levels in healthy Koreans,” Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, vol. 529, no. 1-2, pp. 77–86, 2003.

S. Morais, K. Lima, S. Siqueira et al., “Correlação entre as atividades antiradical, antiacetilcolinesterase e teor de fenóis totais de extratos de plantas medicinais de farmácias vivas,” Revista Brasileira de Plantas Medicinais, vol. 15, no. 4, pp. 575–582, 2013.

C. M. Feitosa, R. M. Freitas, N. N. N. Luz, M. Z. B. Bezerra, and M. T. S. Trevisan, “Acetylcholinesterase inhibition by somes promising Brazilian medicinal plants,” Brazilian Journal of Biology, vol. 71, no. 3, pp. 783–789, 2011.

M.-J. R. Howes and P. J. Houghton, “Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function,” Pharmacology Biochemistry and Behavior, vol. 75, no. 3, pp. 513–527, 2003.

A. B. Penido, S. M. De Morais, A. B. Ribeiro, and A. Z. Silva, “Ethnobotanical study of medicinal plants in imperatriz, state of Maranhão, Northeastern Brazil,” Acta Amazonica, vol. 46, no. 4, pp. 345–354, 2016.

C. M. Sousa, H. R. Silva, G. M. Jr. Vieira et al., “Fenóis totais e atividade antioxidante de cinco plantas medicinais,” Química Nova, vol. 30, no. 2, pp. 351–355, 2007.

C. S. Funari and V. O. Ferro, “Análise de própolis,” Ciência e Tecnologia de Alimentos, vol. 26, no. 1, pp. 171–178, 2006.

C. A. Carvalho, M. V. Lourenço, B. W. Bertoni et al., “Atividade antioxidante de Jacaranda decurrens Cham., Bignoniaceae,” Revista Brasileira de Farmacognosia, vol. 19, no. 2B, pp. 592–598, 2009.

R. Re, N. Pellegrini, A. Proteggente, A. Pannala, M. Yang, and C. Rice-Evans, “Antioxidant activity applying an improved ABTS radical cation decolorization assay,” Free Radical Biology and Medicine, vol. 26, no. 9-10, pp. 1231–1237, 1999.

E. Haslam, “Natural polyphenols (vegetable tannins) as drugs: possible modes of action,” Journal of Natural Products, vol. 59, no. 2, pp. 205–215, 1996.

F. Gonzalez-Mujica, N. Motta, and A. Becerra, “Inhibition of hepatic neoglucogenesis and glucose-6-phosphatase by aqueous extract of Bauhinia megalandra leaves,” Phytotherapy Research, vol. 12, no. 4, pp. 291–293, 1998.

A. M. da Cunha, S. Menon, R. Menon, A. G. Couto, C. Bürger, and M. W. Biavatti, “Hypoglycemic activity of dried extracts of Bauhinia forficata Link,” Phytomedicine, vol. 17, no. 1, pp. 37–41, 2010.

G. S. Marques, L. R. Rolim, L. D. S. Alves et al., “Estado da arte de Bauhinia forficataLink (Fabaceae) como alternativa terapêutica para o tratamento do diabetes melittus,” Revista de Ciências Farmacêuticas Básica e Aplicada, vol. 34, no. 3, pp. 313–320, 2013.

L. A. F. Paiva, K. M. De Alencar Cunha, F. A. Santos, N. V. Gramosa, E. R. Silveira, and V. S. N. Rao, “Investigation on the wound healing activity of oleo-resin from Copaifera langsdorffi in rats,” Phytotherapy Research, vol. 16, no. 8, pp. 737–739, 2002.

L. A. F. Paiva, L. A. Gurgel, E. T. De Sousa et al., “Protective effect of Copaifera langsdorffii oleo-resin against acetic acid-induced colitis in rats,” Journal of Ethnopharmacology, vol. 93, no. 1, pp. 51–56, 2004.

H. P. F. Maciel, C. M. C. P. Gouvêa, M. Toyama, M. Smolka, S. Marangoni, and G. M. Pastore, “Extraction, purification and biochemical characterization of a peroxidase from Copaifera langsdorffii leaves,” Quimica Nova, vol. 30, no. 5, pp. 1067–1071, 2007.

J. B. Sousa, D. Nanayakkara, A. Silva, and J. K. Bastos, “Leishmanicidal and antimalarial activities of crude extracts from aerial parts of Copaifera langsdorffii and isolation of secondary metabolites,” Journal of Pharmacy Research, vol. 5, no. 8, pp. 4103–4107, 2012.

Y. Okada, T. Motoya, S. Tanimoto, and M. Nomura, “A study on fatty acids in seeds of Euterpe oleracea Mart seeds,” Journal of Oleo Science, vol. 60, no. 9, pp. 463–467, 2011.

H. A. S. Favacho, B. R. Oliveira, K. C. Santos et al., “Anti-inflammatory and antinociceptive activities of Euterpe oleracea oil,” Brazilian Journal of Pharmacognosy, vol. 21, no. 1, pp. 105–114, 2011.

R. S. De Moura and Â. C. Resende, “Cardiovascular and Metabolic Effects of Açaí, an Amazon Plant,” Journal of Cardiovascular Pharmacology, vol. 68, no. 1, pp. 19–26, 2016.

H. C. Ferreira, C. P. Serra, D. C. Endringer, V. S. Lemos, F. C. Braga, and S. F. Cortes, “Endothelium-dependent vasodilation induced by Hancornia speciosa in rat superior mesenteric artery,” Phytomedicine, vol. 14, no. 7-8, pp. 473–478, 2007.

G. C. Silva, F. C. Braga, M. P. Lima, J. L. Pesquero, V. S. Lemos, and S. F. Cortes, “Hancornia speciosa Gomes induces hypotensive effect through inhibition of ACE and increase on NO,” Journal of Ethnopharmacology, vol. 137, no. 1, pp. 709–713, 2011.

R. L. Da Rosa, G. M. Nardi, A. G. De Farias Januário et al., “Anti-inflammatory, analgesic, and immunostimulatory effects of luehea divaricata mart. & zucc. (Malvaceae) bark,” Brazilian Journal of Pharmaceutical Sciences, vol. 50, no. 3, pp. 600–610, 2014.

K. Shah, M. Patel, R. Patel, and P. Parmar, “Mangifera Indica (Mango),” Pharmacognosy Reviews, vol. 4, no. 7, pp. 42–48, 2010.

R. S. Guedes, E. U. Alves, M. S. de Medeiros, R. Bruno, E. Gonçalves, and E. Costa, “Armazenamento de sementes de Myracrodruon urundeuva Fr. All. em diferentes embalagens e ambientes,” Revista Brasileira de Plantas Medicinais, vol. 14, no. 1, pp. 68–75, 2012.

V. M. De Moura, L. A. Freitas De Sousa, M. Cristina Dos-Santos et al., “Plants used to treat snakebites in Santarém, western Pará, Brazil: an assessment of their effectiveness in inhibiting hemorrhagic activity induced by Bothrops jararaca venom,” Journal of Ethnopharmacology, vol. 161, pp. 224–232, 2015.

X. Lozoya, H. Reyes-Morales, M. A. Chávez-Soto, M. D. C. Martínez-García, Y. Soto-González, and S. V. Doubova, “Intestinal anti-spasmodic effect of a phytodrug of Psidium guajava folia in the treatment of acute diarrheic disease,” Journal of Ethnopharmacology, vol. 83, no. 1-2, pp. 19–24, 2002.

K. H. Musa, A. Abdullah, and V. Subramaniam, “Flavonoid profile and antioxidant activity of pink guava,” ScienceAsia, vol. 41, no. 3, pp. 149–154, 2015.

A. F. R. M. Michel, M. M. Melo, P. P. Campos et al., “Evaluation of anti-inflammatory, antiangiogenic and antiproliferative activities of Arrabidaea chica crude extracts,” Journal of Ethnopharmacology, vol. 165, pp. 29–38, 2015.

A. M. D. Zocoler, A. C. C. Sanches, I. Albrecht, and J. C. P. De Mello, “Antioxidant capacity of extracts and isolated compounds from Stryphnodendron obovatum Benth,” Brazilian Journal of Pharmaceutical Sciences, vol. 45, no. 3, pp. 443–452, 2009.

S. Aazza, B. Lyoussi, and M. G. Miguel, “Antioxidant activity of some Morrocan hydrosols,” Journal of Medicinal Plants Research, vol. 5, no. 30, pp. 6688–6696, 2011.

A. Khathi, M. R. Serumula, R. B. Myburg, F. R. Van Heerden, and C. T. Musabayane, “Effects of Syzygium aromaticum-derived triterpenes on postprandial blood glucose in streptozotocin-induced diabetic rats following carbohydrate challenge,” PLoS ONE, vol. 8, no. 11, Article ID e81632, 2013.

M. Wettasinghe and F. Shahidi, “Antioxidant and free radical-scavenging properties of ethanolic extracts of defatted borage (Borago officinalis L.) seeds,” Food Chemistry, vol. 67, no. 4, pp. 399–414, 1999.

G. L. Ellman, K. D. Courtney, V. Andres Jr., and R. M. Featherstone, “A new and rapid colorimetric determination of acetylcholinesterase activity,” Biochemical Pharmacology, vol. 7, no. 2, pp. 88–95, 1961.

I. K. Rhee, M. van de Meent, K. Ingkaninan, and R. Verpoorte, “Screening for acetylcholinesterase inhibitors from Amaryllidaceae using silica gel thin-layer chromatography in combination with bioactivity staining,” Journal of Chromatography A, vol. 915, no. 1-2, pp. 217–223, 2001.

M. T. Trevisan, F. V. Macedo, M. Van De Meent, I. K. Rhee, and R. Verpoorte, “Seleção de plantas com atividade anticolinasterase para tratamento da doença de Alzheimer,” Química Nova, vol. 26, no. 3, pp. 301–304, 2003.

J. P. Dzoyem and J. N. Eloff, “Anti-inflammatory, anticholinesterase and antioxidant activity of leaf extracts of twelve plants used traditionally to alleviate pain and inflammation in South Africa,” Journal of Ethnopharmacology, vol. 160, pp. 194–201, 2015.

C. F. Assumpção, P. Bachiega, M. C. Morzelle et al., “Characterization, antioxidant potential and cytotoxic study of mangaba fruits,” Ciência Rural, vol. 44, no. 7, pp. 1297–1303, 2014.

Y. Chen, J. Zhang, B. Zhang, and C.-X. Gong, “Targeting insulin signaling for the treatment of Alzheimer's disease,” Current Topics in Medicinal Chemistry, vol. 16, no. 5, pp. 485–492, 2016.

I. Uriarte-Pueyo and M. I. Calvo, “Flavonoids as acetylcholinesterase inhibitors,” Current Medicinal Chemistry, vol. 18, no. 34, pp. 5289–5302, 2011.

M. Lemos, J. R. Santin, C. S. Mizuno et al., “Copaifera langsdorffii: evaluation of potential gastroprotective of extract and isolated compounds obtained from leaves,” Brazilian Journal of Pharmacognosy, vol. 25, no. 3, pp. 238–245, 2015.

C. Feitosa, A. N. Cavalcante, S. K. M. Chaves, and L. Da Silva Araujo, “Medicinal plants of Brazil and Alzheimer's disease: Evolution in traditional use and pre-clinical studies,” Asian Journal of Biomedical and Pharmaceutical Sciences, vol. 6, no. 58, pp. 1–13, 2016.

J. Wattanathorn, S. Muchimapura, W. Thukham-Mee, K. Ingkaninan, and S. Wittaya-Areekul, “Mangifera indica fruit extract improves memory impairment, cholinergic dysfunction, and oxidative stress damage in animal model of mild cognitive impairment,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 132097, 7 pages, 2014.

G. S. B. Viana, M. A. M. Bandeira, and F. J. A. Matos, “Analgesic and antiinflammatory effects of chalcones isolated from Myracrodruon urundeuva Allemão,” Phytomedicine, vol. 10, no. 2-3, pp. 189–195, 2003.

I. Calou, M. A. Bandeira, W. Aguiar-Galvão et al., “Neuroprotective properties of a standardized extract from Myracrodruon urundeuva Fr. All. (Aroeira-Do-Sertão), as evaluated by a Parkinson's disease model in rats,” Parkinson's Disease, vol. 2014, Article ID 519615, 11 pages, 2014.

S. M. Iha, K. F. Migliato, J. C. Vellosa et al., “Estudo fitoquímico de goiaba (Psidium guajava L.) com potencial antioxidante para o desenvolvimento de formulação fitocosmética,” Revista Brasileira de Farmacognosia, vol. 18, no. 3, pp. 387–393, 2008.